ArticleHarvard review of psychiatry2025
Case Report: Personalizing Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression for a Patient with Complex Medical History.
Article in Harvard review of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients presenting with treatment-resistant depression (TRD) often have complex medical comorbidities that can limit the use of new and novel treatments. Transcranial magnetic stimulation (TMS) is FDA-approved and, overall, has a low adverse side-effect profile. Consensus guidelines, however, are broad and lack specificity around managing individual patient risk. Therefore, individual clinicians must make significant determinations about candidacy and risk management in medically complex patient presentations. This case report details a 49-year-old male with a 10-year history of major depressive disorder with significant medical comorbidity (chronic pain, post-thyroidectomy hypocalcemia secondary to hypoparathyroidism, and basal ganglia calcifications). We illustrate how interdisciplinary care coordination can allow for safe and effective use of TMS in a medically complex patient with severe TRD. This case highlights the importance of personalized treatment planning to expand access to neuromodulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.